Mass General Brigham, Inc

Position in TNGX — Tango Therapeutics, Inc.

CIK 1678378 SOMERVILLE, MA

Position in TNGX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$11,072,041

+$3,662,345 QoQ

Shares Held

354,192

0.0% QoQ

Ownership

0.210%

of shares outstanding

% of Portfolio

6.78%

of 13F equity value

Holder Rank

#73

of 247 holders

Holding Since

Mar 2024

6 quarters on record

Healthcare · as of Jun 30, 2026

Mass General Brigham, Inc holds $82,674,823 across 3 Biotechnology names. TNGX ranks #2 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	344,091	$64,441,362
2	TNGX	Tango Therapeutics, Inc. This page	354,192	$11,072,041
3	MAZE	Maze Therapeutics, Inc.	239,994	$7,161,420

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,072,041	354,192	0.0%	Shares	Sole	2026-08-07
2026-03-31	$7,409,696	354,192	0.0%	Shares	Sole	2026-05-05
2025-12-31	$3,138,141	354,192	0.0%	Shares	Sole	2026-01-27
2024-09-30	$2,727,278	354,192	0.0%	Shares	Sole	2024-10-16
2024-06-30	$3,038,967	354,192	0.0%	Shares	Sole	2024-07-31
2024-03-31	$2,812,284	354,192	—	Shares	Sole	2024-04-04
No filing history on record for this holder in this stock.